Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PTGX Protagonist Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $141.86 +3.3% | $14.86 -2.5% |
| StockIQ Score | 41D Weak Risk: Medium | 36F Weak Risk: Medium |
| Technical | 39F | 13F |
| Fundamental | 30F | 35F |
| Growth | 26F | 50C- |
| Fair Value | 38F | 38F |
| News | 86A | 50C- |
| Quality | 42D | 50C- |
| Risk | 64C+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
PTGX leads in technical analysis with a score of 63 compared to AAPG's 13, and also has a higher investorScore of 47 versus AAPG's 35 and a MODERATE rating versus WEAK. Conversely, AAPG outpaces PTGX in fundamentalScore (35 vs 30) and growthScore (50 vs 26), while both share the same valuationScore of 38.
